Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: results from the EMPA-REG OUTCOME trial (Q58565938)

From Wikidata

Jump to navigation Jump to search

article

Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA-REG OUTCOME trial

Language	Label	Description	Also known as
English	Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: results from the EMPA-REG OUTCOME trial	article	Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA-REG OUTCOME trial

Statements

scholarly article

0 references

Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: results from the EMPA-REG OUTCOME trial (English)

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Maximilian von Eynatten

5

object named as

Maximilian von Eynatten

0 references

Christoph Wanner

6

object named as

Christoph Wanner

0 references

author name string

Takashi Kadowaki

1

0 references

Masaomi Nangaku

2

0 references

Stefan Hantel

3

0 references

Tomoo Okamura

4

0 references

Audrey Koitka-Weber

7

0 references

language of work or name

0 references

publication date

9 November 2018

0 references

Journal of Diabetes Investigation

0 references

10

0 references

3

0 references

760-770

0 references

Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reducing population salt intake worldwide: from evidence to implementation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in progression of CKD and mortality amongst Caucasian, Oriental Asian and South Asian CKD patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cohort study on the rate of progression of diabetic chronic kidney disease in different ethnic groups

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of chronic kidney disease in a multi-ethnic community cohort of patients with diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of type 2 diabetes in South Asians.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes and associated complications in the South Asian population

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Racial differences in sensitivity of blood pressure to aldosterone

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular complications of diabetic kidney disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in risk factors for the onset of albuminuria and decrease in glomerular filtration rate in people with Type 2 diabetes mellitus: implications for the pathogenesis of diabetic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ethnic disparities in risk of cardiovascular disease, end-stage renal disease and all-cause mortality: a prospective study among Asian people with Type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term diabetes outcomes in multi-ethnic Asians living in Singapore

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of Renal Function Decline in Chinese Patients with Type 2 Diabetes Mellitus and in a Subgroup of Normoalbuminuria: A Retrospective Cohort Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease　- Results From EMPA-REG OUTCOME®.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insights from Screening a Racially and Ethnically Diverse Population for Chronic Kidney Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic kidney disease: world wide difference of prevalence and risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated tissue sodium deposition in patients with type 2 diabetes on hemodialysis detected by 23Na magnetic resonance imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erratum: Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD

1 reference

https://pubmed.ncbi.nlm.nih.gov/30412655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/JDI.12971

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58565938&oldid=2254912687"